Health inequalities modular update to NICE health technology evaluations: the manual (PMG36) Methods / process manual consultation NICE process and methods 31 January 2025 Highly specialised ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

For further information on the guideline development process, please see how we develop NICE guidelines ...

For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing. We’ve issued final ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

79% of our recommendations on cancer drugs have been positive (recommended, optimised, or recommended for the Cancer Drugs Fund). This means the committee appraising the drug approved its use in line ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

For further information on the guideline development process, please see how we develop NICE guidelines ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

For further information on the guideline development process, please see how we develop NICE guidelines ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.